E

Eupraxia Pharmaceuticals
D

EPRX

6.28000
USD
-0.16
(-2.48%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
318,071,519
أصول ذات صلة المقالات

العنوان: Eupraxia Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.